FOXM1 and cervical carcinoma: Based on our previous studies, it was hypothesized that the FOXM1-ABCC5 axis contributes to paclitaxel resistance in cervical cancer cells, and this formed the subject of the present study, with the aim of identifying novel therapeutic targets to overcome paclitaxel resistance in cervical cancer cells.